Eli Lilly LLY Peer Comparison

NYSE LLY
$1,124.26 +0.35 (+0.03%)
As of: Sep 9, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

The table below compares all 300 Pharmaceuticals companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 643.26 Bn 30.58 6.57 622.50 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 443.31 Bn 70.19 6.89 436.74 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 364.74 Bn 115.10 5.48 357.60 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 266.46 Bn 9.25 3.88 258.77 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 158.57 Bn 36.30 2.49 146.88 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 52.33 Bn 11.23 0.98 44.95 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 43.79 Bn -24.76 — 43.79 Bn
8 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 15.65 4.34 20.69 Bn
9 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 21.67 Bn 16.53 6.87 19.01 Bn
10 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 22.19 4.64 15.26 Bn
11 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.22 Bn 16.17 3.31 13.60 Bn
12 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 16.98 6.00 13.78 Bn
13 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 12.16 Bn 224.28 14.63 11.85 Bn
14 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 11.32 Bn -37.78 107.81 10.63 Bn
15 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.84 14.02 10.57 Bn
16 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 9.79 Bn -13.35 144.68 8.62 Bn
17 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
18 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
19 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.96 Bn -47.63 — 8.96 Bn
20 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.58 Bn 114.56 4.54 6.92 Bn
21 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.21 Bn -142.87 10.50 6.09 Bn
22 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 6.15 Bn 0.08 — 6.15 Bn
23 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.14 Bn 44.31 13.62 5.86 Bn
24 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -219.71 32.00 5.64 Bn
25 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.76 Bn 12.50 4.18 3.80 Bn
26 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.67 Bn -23.69 — 4.67 Bn
27 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.18 Bn -11.83 — 4.18 Bn
28 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.13 Bn 11.63 3.10 3.91 Bn
29 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.00 Bn -46.48 — 4.00 Bn
30 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
31 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -45.13 — 3.80 Bn
32 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -76.58 5.93 3.14 Bn
33 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.59 Bn 17.20 0.59 2.46 Bn
34 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.81 Bn -10.83 394.49 2.81 Bn
35 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn 4.54 0.06 -3.19 Bn
36 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -61.67 — 2.60 Bn
37 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -7.41 — 2.59 Bn
38 BEIGF BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
39 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.71 3.10 2.07 Bn
40 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.50 2.51 1.60 Bn
41 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.11 13.44 2.28 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.18 Bn -41.21 — 1.87 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.70 6.76 1.66 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.63 Bn 170.39 16.23 1.60 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 7.91 3.01 0.97 Bn
46 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -23.70 — 1.43 Bn
47 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.04 5.10 1.32 Bn
48 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -77.52 3.97 1.21 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -30.70 1.98 0.86 Bn
50 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.09 Bn -5.32 — 1.09 Bn
51 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.53 13.95 1.08 Bn
52 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 69.58 1.37 0.77 Bn
53 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -15.00 22.74 0.75 Bn
54 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -11.54 — 0.73 Bn
55 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -48.72 — 0.91 Bn
56 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -6.91 9.10 0.66 Bn
57 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.75 Bn 15.72 0.93 0.60 Bn
58 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn -7.42 3.04 0.54 Bn
59 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 5.24 0.49 Bn
60 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.70 Bn -38.15 5.90 0.65 Bn
61 IVEVF Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
62 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -8.19 11.84 0.54 Bn
63 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.07 1.70 0.38 Bn
64 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.10 — 0.63 Bn
65 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -16.41 1.78 0.52 Bn
66 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -17.80 — 0.54 Bn
67 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.37 334.91 0.41 Bn
68 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.36 4.46 0.38 Bn
69 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.99 28.37 0.25 Bn
70 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.43 877.24 0.31 Bn
71 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -6.43 — 0.26 Bn
72 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -87.86 11.34 0.42 Bn
73 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -52.78 — 0.41 Bn
74 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -3.47 — 0.34 Bn
75 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn — — 0.33 Bn
76 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.15 1.47 0.15 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.02 — 0.30 Bn
78 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -1.67 0.38 0.15 Bn
79 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.29 — 0.29 Bn
80 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.94 — 0.27 Bn
81 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.70 1.18 0.10 Bn
82 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.03 0.00 -10.83 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn — — 0.07 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.33 7.32 0.21 Bn
85 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -55.91 3.00 0.18 Bn
86 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.59 — 0.20 Bn
87 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -38.89 8.50 0.20 Bn
88 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.17 14.71 0.16 Bn
89 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.55 108.38 0.15 Bn
90 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -29.09 — 0.19 Bn
91 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.42 — 0.12 Bn
92 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -46.69 — 0.16 Bn
93 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.19 7.19 0.15 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.33 — 0.13 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.22 — 0.10 Bn
96 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.48 3.60 0.10 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.55 — 0.03 Bn
98 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.49 — 0.10 Bn
99 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -8.86 3.05 0.09 Bn
100 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.47 — 0.09 Bn
101 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.99 — 0.09 Bn
102 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -7.67 100.93 0.09 Bn
103 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -0.76 1.57 0.06 Bn
104 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.07 Bn
105 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.20 — -0.01 Bn
106 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.77 — 0.07 Bn
107 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
108 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 115.53 — 0.03 Bn
109 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.30 0.96 -0.01 Bn
110 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.25 0.33 -0.02 Bn
111 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.95 — 0.05 Bn
112 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.36 217.73 0.05 Bn
113 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.41 — 0.04 Bn
114 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.84 — 0.04 Bn
115 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.85 — 0.04 Bn
116 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.13 -0.08 Bn
117 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.34 2.90 0.02 Bn
118 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.51 — 0.03 Bn
119 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.01 8.02 0.03 Bn
120 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
121 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.85 77.46 0.03 Bn
122 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.20 50.30 0.00 Bn
123 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -2.97 — 0.03 Bn
124 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -132.69 7.51 0.02 Bn
125 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.73 0.40 0.00 Bn
126 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.72 — 0.02 Bn
127 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.67 808.26 0.02 Bn
128 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.28 0.45 0.02 Bn
129 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.56 — 0.01 Bn
130 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.67 — 0.02 Bn
131 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.41 — 0.02 Bn
132 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.17 0.02 Bn
133 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.64 — 0.01 Bn
134 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.67 — 0.01 Bn
135 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.38 -9.36 -0.01 Bn
136 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.74 — 0.01 Bn
137 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
138 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
139 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.80 — 0.00 Bn
140 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
141 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.41 — 0.01 Bn
142 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.32 — 0.01 Bn
143 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.93 1,256.38 0.00 Bn
144 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
145 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.30 — 0.00 Bn
146 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
147 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.22 — 0.00 Bn
148 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.24 5.93 0.00 Bn
149 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
150 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
151 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
152 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.05 54.04 0.00 Bn
153 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
154 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
155 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
156 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
157 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.01 -0.01 Bn
158 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
159 CINGW Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.74 Bn
163 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 5.94 177.74 Bn
164 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 10.50 124.30 Bn
165 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 5.34 74.90 Bn
166 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 11.75 56.23 Bn
167 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 24.23 48.85 Bn
168 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.84 Bn 61.56 2.47 39.19 Bn
169 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 7.18 31.18 Bn
170 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 33.70 Bn 52.41 3.13 32.24 Bn
171 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 3.11 29.86 Bn
172 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 2,751.33 30.05 Bn
173 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.54 Bn 14.41 1.39 27.44 Bn
174 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 24.60 26.83 Bn
175 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 7.67 10.06 Bn
176 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.13 Bn -46.58 1.30 18.24 Bn
177 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.20 Bn 21.48 2.14 17.79 Bn
178 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 12.36 15.03 Bn
179 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 11.19 14.92 Bn
180 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 20.89 14.18 Bn
181 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.38 Bn 40.38 4.09 13.77 Bn
182 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
183 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 7.56 12.35 Bn
184 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 3.65 11.57 Bn
185 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 17.69 10.24 Bn
186 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
187 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.58 Bn -67.15 17.26 10.46 Bn
188 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
189 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.11 Bn 18.88 3.21 9.51 Bn
190 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
191 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.91 Bn 785.46 2.70 9.74 Bn
192 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 33.92 9.56 Bn
193 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 10.57 7.18 Bn
194 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
195 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 51.11 8.12 Bn
196 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
197 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 9.72 7.09 Bn
198 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
199 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
200 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
201 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 28.90 6.60 Bn
202 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 1,021.85 6.36 Bn
203 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.33 Bn -38.86 1.19 5.96 Bn
204 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 4,533.84 6.31 Bn
205 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 10.12 5.82 Bn
206 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
207 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
208 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
209 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 1,160.93 5.65 Bn
210 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 19.90 4.42 Bn
211 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
212 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
213 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.51 Bn 25.57 1.77 5.38 Bn
214 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
215 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
216 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
217 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 1,126.80 4.06 Bn
218 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
219 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
220 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
221 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 366.70 3.80 Bn
222 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -18.13 11.66 3.49 Bn
223 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
224 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 30.64 2.88 Bn
225 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 66.37 2.56 Bn
226 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 15.11 2.71 Bn
227 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 50.98 3.37 Bn
228 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
229 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 6.70 2.87 Bn
230 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 19,122.53 3.02 Bn
231 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
232 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 593.06 2.44 Bn
233 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
234 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 79.61 2.48 Bn
235 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 6.24 2.10 Bn
236 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.66 Bn -22.42 2.03 2.56 Bn
237 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
238 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 49.52 2.58 Bn
239 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.51 Bn -169.96 10.01 2.40 Bn
240 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
241 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
242 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 33.69 2.40 Bn
243 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -16.97 1.18 1.53 Bn
244 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -2.11 0.21 0.46 Bn
245 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
246 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 4.28 1.94 Bn
247 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 12.04 2.16 Bn
248 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
249 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
250 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 4.19 2.01 Bn
251 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.34 0.63 Bn
252 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
253 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 20.99 2.06 Bn
254 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 102.87 2.06 Bn
255 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
256 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.16 2.03 Bn
257 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 53.36 1.71 Bn
258 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 71.80 1.69 Bn
259 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 18.04 1.52 Bn
260 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 6.00 1.82 Bn
261 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 7.00 1.22 Bn
262 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 1,357.12 1.76 Bn
263 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 4.06 0.87 Bn
264 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
265 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.30 1.17 Bn
266 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 17.33 1.71 Bn
267 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
268 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
269 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 3.93 0.91 Bn
270 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 943.71 1.62 Bn
271 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 8.06 1.32 Bn
272 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
273 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 523.75 1.59 Bn
274 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
275 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
276 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.49 Bn 13.80 1.52 1.13 Bn
277 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 2.04 1.17 Bn
278 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
279 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.27 1.45 Bn
280 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 50.20 0.81 Bn
281 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.48 5.56 1.03 Bn
282 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
283 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
284 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
285 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 36.50 1.40 Bn
286 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
287 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 876.13 1.17 Bn
288 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
289 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
290 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
291 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.67 0.75 Bn
292 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
293 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 3.10 1.11 Bn
294 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 50.76 1.22 Bn
295 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
296 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
297 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -4.64 22.98 0.66 Bn
298 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.92 Bn
299 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
300 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn